EdgarLookup

MANNKIND CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that MANNKIND CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
1.7%
Profit Margin
Net income ÷ revenue
0.7%
Return on Assets
Net income ÷ assets
-16.53x
Debt-to-Equity
Total liabilities ÷ equity
+22.2%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $348.97M Feb 26, 2026
FY2025 Dec 31, 2024 $285.50M Feb 26, 2026
FY2025 Dec 31, 2023 $198.96M Feb 26, 2026
FY2024 Dec 31, 2022 $99.77M Feb 26, 2025
FY2023 Dec 31, 2021 $75.44M Feb 27, 2024
FY2022 Dec 31, 2020 $65.14M Feb 23, 2023
FY2019 Dec 31, 2019 $15.99M Feb 25, 2020
FY2019 Sep 30, 2019 $14.60M Feb 25, 2020
FY2019 Jun 30, 2019 $15.00M Feb 25, 2020
FY2019 Mar 31, 2019 $17.45M Feb 25, 2020

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $4.53M Feb 27, 2018
FY2017 Sep 30, 2017 $2.04M Feb 27, 2018
FY2017 Jun 30, 2017 $2.16M Feb 27, 2018
FY2017 Mar 31, 2017 $3.01M Feb 27, 2018
FY2017 Dec 31, 2016 $12.40M Feb 27, 2018
FY2017 Sep 30, 2016 $162.35M Feb 27, 2018
FY2015 Dec 31, 2015 $0 Mar 15, 2016
FY2015 Dec 31, 2014 $0 Mar 15, 2016
FY2015 Dec 31, 2013 $0 Mar 15, 2016
FY2014 Dec 31, 2012 $35.0K Mar 2, 2015

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.86M Feb 26, 2026
FY2025 Dec 31, 2024 $27.59M Feb 26, 2026
FY2025 Dec 31, 2023 ($11.94M) Feb 26, 2026
FY2024 Dec 31, 2022 ($87.40M) Feb 26, 2025
FY2023 Dec 31, 2021 ($80.93M) Feb 27, 2024
FY2022 Dec 31, 2020 ($57.24M) Feb 23, 2023
FY2019 Dec 31, 2019 ($14.26M) Feb 25, 2020
FY2019 Sep 30, 2019 ($10.37M) Feb 25, 2020
FY2019 Jun 30, 2019 ($12.39M) Feb 25, 2020
FY2019 Mar 31, 2019 ($14.88M) Feb 25, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $38.80M Feb 26, 2026
FY2025 Dec 31, 2024 $72.59M Feb 26, 2026
FY2025 Dec 31, 2023 $8.68M Feb 26, 2026
FY2024 Dec 31, 2022 ($64.11M) Feb 26, 2025
FY2023 Dec 31, 2021 ($47.02M) Feb 27, 2024
FY2022 Dec 31, 2020 ($47.91M) Feb 23, 2023
FY2020 Dec 31, 2019 ($44.60M) Feb 25, 2021
FY2019 Dec 31, 2018 ($76.60M) Feb 25, 2020
FY2018 Dec 31, 2017 ($108.19M) Feb 26, 2019
FY2018 Dec 31, 2016 $67.26M Feb 26, 2019

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $144.14M Feb 26, 2026
FY2025 Dec 31, 2024 $94.33M Feb 26, 2026
FY2025 Dec 31, 2023 $94.31M Feb 26, 2026
FY2024 Dec 31, 2022 $91.47M Feb 26, 2025
FY2021 Dec 31, 2021 $77.42M Feb 24, 2022
FY2021 Dec 31, 2020 $59.04M Feb 24, 2022
FY2020 Dec 31, 2019 $74.67M Feb 25, 2021
FY2019 Dec 31, 2018 $79.72M Feb 25, 2020
FY2018 Dec 31, 2017 $74.96M Feb 26, 2019
FY2018 Dec 31, 2016 $46.93M Feb 26, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $18.26M Feb 26, 2026
FY2025 Dec 31, 2024 $42.51M Feb 26, 2026
FY2025 Dec 31, 2023 $34.09M Feb 26, 2026
FY2024 Dec 31, 2022 ($80.68M) Feb 26, 2025
FY2023 Dec 31, 2021 ($61.71M) Feb 27, 2024
FY2022 Dec 31, 2020 ($28.13M) Feb 23, 2023
FY2020 Dec 31, 2019 ($88.48M) Feb 25, 2021
FY2019 Dec 31, 2018 ($37.73M) Feb 25, 2020
FY2018 Dec 31, 2017 ($64.78M) Feb 26, 2019
FY2018 Dec 31, 2016 ($78.09M) Feb 26, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.57M Feb 26, 2026
FY2025 Dec 31, 2024 $9.69M Feb 26, 2026
FY2025 Dec 31, 2023 $42.44M Feb 26, 2026
FY2024 Dec 31, 2022 $7.59M Feb 26, 2025
FY2023 Dec 31, 2021 $11.47M Feb 27, 2024
FY2022 Dec 31, 2020 $801.0K Feb 23, 2023
FY2020 Dec 31, 2019 $2.57M Feb 25, 2021
FY2019 Dec 31, 2018 $354.0K Feb 25, 2020
FY2018 Dec 31, 2016 $1.14M Feb 26, 2019
FY2017 Dec 31, 2015 $10.29M Feb 27, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $792.18M Feb 26, 2026
FY2025 Dec 31, 2024 $393.84M Feb 26, 2026
FY2024 Dec 31, 2023 $475.20M Feb 26, 2025
FY2023 Dec 31, 2022 $295.28M Feb 27, 2024
FY2022 Dec 31, 2021 $321.16M Feb 23, 2023
FY2021 Dec 31, 2020 $108.61M Feb 24, 2022
FY2020 Dec 31, 2019 $93.73M Feb 25, 2021
FY2019 Dec 31, 2018 $107.71M Feb 25, 2020
FY2018 Dec 31, 2017 $84.58M Feb 26, 2019
FY2017 Dec 31, 2016 $107.06M Feb 27, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $843.20M Feb 26, 2026
FY2025 Dec 31, 2024 $472.66M Feb 26, 2026
FY2024 Dec 31, 2023 $721.37M Feb 26, 2025
FY2023 Dec 31, 2022 $545.82M Feb 27, 2024
FY2022 Dec 31, 2021 $530.51M Feb 23, 2023
FY2021 Dec 31, 2020 $289.03M Feb 24, 2022
FY2020 Dec 31, 2019 $284.25M Feb 25, 2021
FY2019 Dec 31, 2018 $282.79M Feb 25, 2020
FY2018 Dec 31, 2017 $299.31M Feb 26, 2019
FY2017 Dec 31, 2016 $290.66M Feb 27, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($51.02M) Feb 26, 2026
FY2025 Dec 31, 2024 ($78.82M) Feb 26, 2026
FY2025 Dec 31, 2023 ($246.17M) Feb 26, 2026
FY2025 Dec 31, 2022 ($250.54M) Feb 26, 2026
FY2024 Dec 31, 2021 ($209.35M) Feb 26, 2025
FY2023 Dec 31, 2020 ($180.42M) Feb 27, 2024
FY2022 Dec 31, 2019 ($190.53M) Feb 23, 2023
FY2020 Dec 31, 2018 ($175.08M) Feb 25, 2021
FY2019 Dec 31, 2017 ($214.73M) Feb 25, 2020
FY2018 Dec 31, 2016 ($183.59M) Feb 26, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $67.60M Feb 26, 2026
FY2025 Dec 31, 2024 $1.93M Feb 26, 2026
FY2024 Dec 31, 2023 $1.93M Feb 26, 2025
FY2023 Dec 31, 2022 $2.43M Feb 27, 2024
FY2013 Dec 12, 2001 $151.40M Mar 3, 2014

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($3.20B) Feb 26, 2026
FY2025 Dec 31, 2024 ($3.20B) Feb 26, 2026
FY2024 Dec 31, 2023 ($3.23B) Feb 26, 2025
FY2023 Dec 31, 2022 ($3.22B) Feb 27, 2024
FY2022 Dec 31, 2021 ($3.13B) Feb 23, 2023
FY2021 Dec 31, 2020 ($3.05B) Feb 24, 2022
FY2020 Dec 31, 2019 ($2.99B) Feb 25, 2021
FY2019 Dec 31, 2018 ($2.94B) Feb 25, 2020
FY2018 Dec 31, 2017 ($2.85B) Feb 26, 2019
FY2017 Dec 31, 2016 ($2.74B) Feb 27, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $74.88M Feb 26, 2026
FY2025 Dec 31, 2024 $46.34M Feb 26, 2026
FY2024 Dec 31, 2023 $238.48M Feb 26, 2025
FY2023 Dec 31, 2022 $69.77M Feb 27, 2024
FY2022 Dec 31, 2021 $124.18M Feb 23, 2023
FY2021 Dec 31, 2020 $67.01M Feb 24, 2022
FY2020 Dec 31, 2019 $29.91M Feb 25, 2021
FY2019 Dec 31, 2018 $71.16M Feb 25, 2020
FY2018 Dec 31, 2017 $43.95M Feb 26, 2019
FY2017 Dec 31, 2016 $22.90M Feb 27, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $354.64M Feb 26, 2026
FY2025 Dec 31, 2024 $36.05M Feb 26, 2026
FY2024 Dec 31, 2023 $268.70M Feb 26, 2025
FY2023 Dec 31, 2022 $273.49M Feb 27, 2024
FY2022 Dec 31, 2021 $281.20M Feb 23, 2023
FY2021 Dec 31, 2020 $122.24M Feb 24, 2022
FY2020 Dec 31, 2019 $118.90M Feb 25, 2021
FY2019 Dec 31, 2018 $102.49M Feb 25, 2020

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 26, 2026
FY2025 Dec 31, 2024 0 Feb 26, 2026
FY2025 Dec 31, 2023 0 Feb 26, 2026
FY2024 Dec 31, 2022 0 Feb 26, 2025
FY2023 Dec 31, 2021 0 Feb 27, 2024
FY2022 Dec 31, 2020 0 Feb 23, 2023
FY2018 Dec 31, 2018 0 Feb 26, 2019
FY2018 Sep 30, 2018 0 Feb 26, 2019
FY2018 Jun 30, 2018 0 Feb 26, 2019
FY2018 Mar 31, 2018 0 Feb 26, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 26, 2026
FY2025 Dec 31, 2024 0 Feb 26, 2026
FY2025 Dec 31, 2023 0 Feb 26, 2026
FY2024 Dec 31, 2022 0 Feb 26, 2025
FY2023 Dec 31, 2021 0 Feb 27, 2024
FY2022 Dec 31, 2020 0 Feb 23, 2023
FY2018 Dec 31, 2018 0 Feb 26, 2019
FY2018 Sep 30, 2018 0 Feb 26, 2019
FY2018 Jun 30, 2018 0 Feb 26, 2019
FY2018 Mar 31, 2018 0 Feb 26, 2019

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 307.83M Feb 26, 2026
FY2025 Dec 31, 2024 302.96M Feb 26, 2026
FY2024 Dec 31, 2023 270.03M Feb 26, 2025
FY2023 Dec 31, 2022 263.79M Feb 27, 2024
FY2022 Dec 31, 2021 251.48M Feb 23, 2023
FY2021 Dec 31, 2020 242.12M Feb 24, 2022
FY2020 Dec 31, 2019 211.79M Feb 25, 2021
FY2019 Dec 31, 2018 187.03M Feb 25, 2020
FY2018 Dec 31, 2017 119.05M Feb 26, 2019
FY2017 Dec 31, 2016 95.68M Feb 27, 2018